Lack of prescriptions affects Māori diabetes patients

5 November 2020

Metformin is the medication of choice for treating most patients with type 2 diabetes

University of Waikato researchers have found Māori patients receive fewer prescriptions for a common diabetes medication than non-Māori patients, and have worse blood sugar control as a result.

Type 2 diabetes is a growing problem in New Zealand, affecting an increasing number of young people, and twice as many Māori as non-Māori.

Led by Dr Lynne Chepulis at the University of Waikato Medical Research Centre, the team collected data from 10 general practice clinics around the Waikato, focusing on patients with type 2 diabetes who were regular, ongoing users of metformin.

“Metformin is the medication of choice for treating most patients with type 2 diabetes,” says Dr Chepulis. “But when patients don’t receive the required amount, this can lead to poor blood sugar control and increased risk of complications.”

The researchers studied three measures to assess metformin use: prescriptions from doctors, dispensing by pharmacies, and patients’ glycated haemoglobin scores, a marker of their blood sugar levels over time.

They found Māori received fewer prescriptions than non-Māori, but that there was no difference between Māori and non-Māori in adhering to their prescriptions (obtaining them from a pharmacy). However, prescription adherence was lower for younger patients overall, compared to older patients.

In terms of average blood sugar levels, those who were prescribed the recommended amount of medication, and those who obtained 100% of their prescriptions from the pharmacy, had better results. Given that fewer Māori were prescribed the required amount of metformin, their blood sugar levels were worse on average.

“There are many studies using pharmaceutical data showing that Māori are less likely to use medication for diabetes and other illnesses,” says Dr Chepulis. “However this study includes prescription data from primary care, which is generally difficult to get hold of. Being able to include the primary care data shows that this discrepancy in medication use by Māori is actually due to a lack of prescriptions.

“I believe that we are the first in New Zealand to report on combined prescribing and medication dispensing data for diabetes medication use.”

Dr Chepulis says further research is needed to uncover whether the reduced rate of prescribing metformin to Māori patients is related to patient preferences or health system issues. “Understanding ways to improve outcomes for people with diabetes is very important to the health of Māori in particular, as well as New Zealand’s population as a whole,” she says.

This study was supported by funding from the University of Waikato and the New Zealand Society for the Study of Diabetes.

The paper Metformin Adherence in Patients with Type 2 Diabetes and Association with Glycated Haemoglobin Levels was authored by:

  • Dr Lynne Chepulis, University of Waikato
  • Christopher Mayo, University of Waikato (Summer Studentship)
  • Brittany Morison, University of Waikato
  • Dr Rāwiri Keenan, University of Waikato
  • Dr Chunhuan Lao, University of Waikato
  • Dr Ryan G Paul, University of Waikato, Waikato District Health Board
  • Professor Ross Lawrenson, University of Waikato, Waikato District Health Board

This research aligns with the following United Nations Sustainable Development Goals:

Good Health and Well-being Reduced Inequalities

Latest stories

Related stories

Research leader and Antarctica expert to join Waikato as Deputy Vice-Chancellor Research

The University of Waikato has announced the appointment of Professor Gary Wilson to the role…

University of Waikato researchers receive record-level Marsden funding to explore bold ideas for the future

The University of Waikato is celebrating its most successful Marsden funding round yet.

Dr Rebecca Lawton Rutherford Discovery Fellow

Prestigious Rutherford Discovery Fellowship awarded to Dr Rebecca Lawton for marine kelp research

Dr Rebecca Lawton, Senior Lecturer in Marine Science and Aquaculture at the University of Waikato…

Dr Jason Mika

Significant funding boost for University of Waikato research

The University of Waikato has achieved significant results in the latest funding round from the…

Dr Haki Tuaupiki and Associate Professor Maui Hudson

Waikato researchers tapped for US$30m Centre for braiding Indigenous knowledge and science

Two University of Waikato researchers have been shoulder-tapped as investigators within the newly launched NSF…

IDI Lab sign

Newly refurbished Waikato IDI Lab a catalyst for fostering academic-industry collaboration

The University of Waikato re-opened its newly refurbished Integrated Data Infrastructure (IDI) Lab; a catalyst…

3MT group photo 2023

Captive kiwi management researcher takes out tight competition

Te Aka Mātuatua School of Science animal behaviour researcher Rebecca Connor won the University's 3…

Professor Chris Battershill

Renowned scientist honoured for dedication to marine conservation

World-renowned marine scientist Professor Chris Battershill has been honoured for his significant contributions to marine…

Professor Holly Thorpe

Reimagining fields of play to grow the future of women in sport through world-class research

Waikato hosts global symposium to tackle issues from building gender-inclusive sporting environments to menstrual health…

Copyright Todd M. Henry 2020a

Kava based therapy for psychological trauma reaches clinical trial milestone

Waikato Pacific health researcher Dr Apo Aporosa has been awarded a Health Research Council grant…

Gallagher Academy of Performing Arts

Te Kāhui a Kiwa - driving awareness and dialogue on Indigenous trade

Indigenous and international speakers meet this week at the University of Waikato to share their…

Exploring and embracing diversity

Research at the University of Waikato is helping to underpin policy development and decisions designed…